The year was 1943. As a third-year medical student at Stanford, I was
about to witness the beginning of a medical miracle. Dr. Arthur
Bloomfield, Professor of Medicine, had selected my patient, a middle
aged man, who was dying of acute pneumococcal pneumonia, as one of the
first patients to receive miniscule doses (by today's standards) of his
meagre supply of a new drug - penicillin. The patient's response amazed
everyone especially this impressionable medical student. The rest of the
story is history. With one stroke, the introduction of penicillin
removed from the medical scene the 'friend of the aged' - lobar
pneumonia. The consequences, which no one could have imagined at the
time, are still becoming manifest as other 'miracles' such as
respirators, artificial kidneys and many potent new antibiotics have
come upon the scene. All of us are aware that these miracles have
created a variety of new challenges around the states of dying and near
dying. We have no easy answers for these problems. Nevertheless as
dialysis techniques, especially CAPD, are applied more widely to the
treatment of the elderly, the task of helping the patient meet death
with dignity becomes increasingly important and vexing because once
begun, dialysis is difficult to terminate.